Clinical trial
Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory…
NCT00022555 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00022555 |
|---|---|
| Title | Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma |
| Official title | A Phase I Trial of Combination Bryostatin-1 and Vincristine in HIV-Related B-cell Neoplasms |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Small Noncleaved Cell Lymphoma |
| Intervention type | Drug |
| Interventions | bryostatin 1, vincristine sulfate |
| Enrollment | 12 |
| Start date | Nov 1, 2001 |
| Primary completion | Jul 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: